Oxford trial offers new hope for a COVID vaccine

Early stage human trials of a COVID-19 vaccine have found it produces strong immune response and shows no early safety concerns, according to results published today in The Lancet. 

The team of scientists at Oxford University’s Jenner Institute and Oxford Vaccine Group, say they have taken the next step towards the discovery of a safe, effective and accessible vaccine against coronavirus.

The results of the Phase I/II trial published today in the scientific journal, The Lancet, indicate no early safety concerns, and both T-cell and antibody responses against the SARS-CoV-2 virus, including robust neutralising antibody responses were demonstrated.